May
4
14
Deputy Secretary of Defense to DHA: ‘The Work You All Have Done is Unprecedented’
Deputy Secretary of Defense reinforces critical role the Defense Health Agency plays in supporting the Department of Defense mission
This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.
2/27/2008
A drug or biological product subject to the FDA regulations at Part 312 of Title 21, Code of Federal Regulations, Parts 50, 56, 312, Subpart I of Part 314, Subpart G of Part 601, as amended, including: A drug not approved or a biological product not licensed by the FDA and a drug unapproved for its applied use.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.